Research Article
HLA-C Alleles and Cytomegalovirus Retinitis in Brazilian Patients with AIDS
Table 3
HLA-C allele frequencies compared between Groups II (patients with AIDS without CR) and III (healthy HIV-negative individuals).
| Allele | Group II (%) | Group III (%) | Etiologic fraction | OR | Preventive fraction | value |
| HLA-C01 | 1.5 | 1.7 | | | | | HLA-C02 | 3.4 | 5.7 | | | | | HLA-C03 | 10.8 | 6.9 | | | | | HLA-C04 | 17.6 | 15.3 | | | | | HLA-C05 | 8.3 | 4.0 | 0.0455 | 2.2045 | | 0.0169 | HLA-C06 | 7.7 | 9.9 | | | | | HLA-C07 | 26.5 | 26.7 | | | | | HLA-C08 | 3.4 | 5.7 | | | | | HLA-C10 | 0.3 | 0.0 | | | | | HLA-C12 | 5.9 | 6.4 | | | | | HLA-C13 | 0.3 | 0.0 | | | | | HLA-C14 | 1.9 | 2.2 | | | | | HLA-C15 | 3.7 | 3.5 | | | | | HLA-C16 | 3.1 | 8.2 | | 0.3580 | 0.0524 | 0.0041 | HLA-C17 | 4.0 | 3.0 | | | | | HLA-C18 | 1.5 | 0.7 | | | | |
|
|
HLA-C = major histocompatibility complex, class I, C; OR = odds ratio.
|